Abstract:STUDY QUESTIONWhat is the impact of male age- and sperm-related factors on embryonic aneuploidy?SUMMARY ANSWERUsing a 3-fold analysis framework encompassing patient-level, embryo-level, and matching analysis, we found no clinically significant interactions between male age and sperm quality with embryo ploidy.WHAT IS KNOWN ALREADYWhile the effect of maternal age on embryo chromosomal aneuploidy is well-established, the impact of male age and sperm quality on ploidy is less well-defined.STUDY DESIGN, SIZE, DURATIONThis retrospective cohort study analyzed autologous preimplantation genetic testing for aneuploidy (PGT-A) and frozen embryo transfer cycles from December 2014 to June 2021. The study involved 11 087 cycles from 8484 patients, with a total of 35 797 embryos.PARTICIPANTS/MATERIALS, SETTING, METHODSThe aneuploidy rate, calculated as the ratio of aneuploid blastocysts to the total number of blastocysts biopsied in a single treatment cycle, was evaluated. In the embryo-level analysis, the main outcome measure was the ploidy state of the embryos. The study employed a multifaceted analytical approach that included a patient-level analysis using generalized linear mixed models, an embryo-level analysis focusing on chromosomal ploidy, and a propensity score matching analysis contrasting groups with distinct ploidy rates (0% and 100%). There were no interventions as this was an observational study of PGT-A cycles.MAIN RESULTS AND THE ROLE OF CHANCENo clinically relevant factors influencing ploidy rate related to male and sperm quality were revealed. In contrast, female age (coefficient = −0.053), BMI (coefficient = 0.003), prior ART cycle (coefficient = −0.066), and number of oocytes retrieved (coefficient = −0.018) were identified at the patient level. Embryo analysis identified age (coefficient = −0.1244) and ICSI usage (coefficient = −0.0129) as significant factors. Despite these, no significant interactions between male and female assessed factors on the ploidy rate emerged. Propensity score matching between maximal (100% vs 0%) euploid rates did not reveal significant differences of influence by male age and sperm quality.LIMITATIONS, REASONS FOR CAUTIONThe focus on patients having blastocyst biopsy for PGT-A may not reflect the broader IVF population. Other semen quality parameters like DNA fragmentation were not included. Exclusion of embryo mosaicism from the analysis could affect aneuploidy rate interpretations. There may also be unmeasured influences like lifestyle or environmental factors.WIDER IMPLICATIONS OF THE FINDINGSMale age and sperm quality parameters were consistent across both maximal and minimal ploidy rate comparisons. No significant clinical characteristics related to the factors assessed for the male-influenced blastocyst ploidy status, confirming the dominancy of the oocyte and female age.STUDY FUNDING/COMPETING INTEREST(S)The study was not funded. There are no competing interests.TRIAL REGISTRATION NUMBERN/A.

Sperm Has an Impact on Embryonic Development and Clinical Outcomes: A Study of Sibling Oocytes.

Are Testicular Sperms Superior to Ejaculated Sperms in Couples with Previous ART Failure Due to High Rate of Fragmented Embryos? A Retrospective Cohort Study

The Embryological Characteristics and Clinical Outcomes of Oocytes with Indented Zona Pellucida

Fertilizing Ability, Cleavage Potential and Inheritance Risk of Globozoospermia

Effects of donor sperm on perinatal and neonatal outcomes resulting from in vitro fertilization-intracytoplasmic sperm injection and embryo transfer cycles: a retrospective cohort study

What sperm parameters effect blastocyst formation and quality during ICSI with severe male infertility

Do sperm factors influence embryonic aneuploidy? Long live the oocyte

Different sperm sources and parameters can influence intracytoplasmic sperm injection outcomes before embryo implantation

Sperm Selection Using Zona Pellucida–Binding Enhanced Embryo Morphokinetic and Clinical Outcomes in ICSI: A Sibling Oocytes Study

ICSI Treatment of Severe Male Infertility Can Achieve Prospective Embryo Quality Compared with IVF of Fertile Donor Sperm on Sibling Oocytes

[Influence of the DNA Integrity of Optimized Sperm on the Embryonic Development and Clinical Outcomes of in Vitro Fertilization and Embryo Transfer].

The effect of male factors on embryo morphokinetics: a retrospective analysis of 2726 blastocysts

Sperm Origins and Concentration Do Not Impact the Clinical Outcomes in Intracytoplasmic Sperm Injection Cycles

The Use of Frozen Embryos and Frozen Sperm Have Complementary IVF Outcomes: a Retrospective Analysis in Couples Experiencing IVF/Donor and IVF/Husband

Decreased Sperm Motility Retarded ICSI Fertilization Rate in Severe Oligozoospermia but Good-Quality Embryo Transfer Had Achieved the Prospective Clinical Outcomes

Effect of Paternal Body Mass Index on In Vitro Fertilization and Neonatal Outcomes among Oligozoospermia and Asthenospermia Patients

Efficacy of Artificial Oocyte Activation in Patients with Embryo Developmental Problems: a Sibling Oocyte Control Study

Sperm DNA integrity does play a crucial role for embryo development after ICSI, notably when good-quality oocytes from young donors are used

Severe Teratozoospermia Associated With Severe Oligospermia Affects Clinical Outcome In Human Icsi Cycles

Sperm DNA Fragmentation May Influence IUI Outcome but Could Be Treated by ICSI： Evidence from Human Sperm Bank

Artificial Oocyte Activation Improves Cycles with Prospects of ICSI Fertilization Failure: a Sibling Oocyte Control Study.